Abiopharma

🔍 Quisel John D (Executive)

Company: Disc Medicine, Inc. (IRON)

Report Date: 2026-02-10

Detailed Transactions and Holdings:

• Acquired 55,200 shares of Common Stock (Direct)
  Date: 2026-02-10 | Code: A | equity_swap_involved: false | shares_owned_after: 239,328.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 82,800 shares of Stock Option (Right to Buy) at $74.75 per share (Derivative)
  Date: 2026-02-10 | Code: A | Expires: 2036-02-09 | equity_swap_involved: false | shares_owned_after: 82,800.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date.
• F2: The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date.